Sandy Mong
InvestorPartner, MD at Catalys Pacific
About
Sandy Mong is a Partner at Catalys Pacific with experience in business development, corporate strategy, and program leadership across therapeutic areas from discovery to clinical stage. She previously held BD and operations roles at Mariana Oncology (acquired by Novartis), BridgeBio Pharma, and CRISPR Therapeutics, and was a consultant at McKinsey. She holds an MD from Harvard Medical School and a B.S. from Yale University.
Contact· self-published, not guessed
Invests in
Biotech
Colleagues at Catalys Pacific
Ariel Miura
Analyst at Catalys Pacific
Ashwin Ram
Partner at Catalys Pacific
Brian Taylor Slingsby
Founder & Managing Director, MD, PhD, MPH at Catalys Pacific
BT Slingsby
Founder and Managing Director at Catalys Pacific
Hayato Urabe
Vice President at Catalys Pacific
Hidemasa Tanigaki
Operating Partner at Catalys Pacific
Hiromi Miwa
Principal at Catalys Pacific
Jay Shepard
Venture Partner at Catalys Pacific
Frequently asked questions
- Who is Sandy Mong?
- Sandy Mong is a Partner at Catalys Pacific with experience in business development, corporate strategy, and program leadership across therapeutic areas from discovery to clinical stage. She previously held BD and operations roles at Mariana Oncology (acquired by Novartis), BridgeBio Pharma, and CRISPR Therapeutics, and was a consultant at McKinsey. She holds an MD from Harvard Medical School and a B.S. from Yale University.
- Where does Sandy Mong work?
- Sandy Mong is Partner, MD at Catalys Pacific.
- What does Sandy Mong invest in?
- Sandy Mong invests in Biotech.